ASTRO publishes template for long-term survivor plans

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY published a new template that standardizes and streamlines the creation of patient-focused plans for long-term cancer survivor care following radiation therapy.

The template and related research papers, “Development of a Standard Survivorship Care Plan for Radiation Oncologists” and “U.S. Radiation Oncology Practice Patterns for Post-Treatment Survivor Care,” are published in Practical Radiation Oncology, the official clinical journal of ASTRO.

The template was developed to coordinate post-treatment care for cancer survivors among the various contributors to their care, including primary care providers and oncology specialists, as well as patients.

The framework also helps practices meet new accreditation requirements set by the American College of Surgeons Commission on Cancer. In response to a 2006 recommendation from the Institutes of Medicine that cancer patients be provided with a survivorship care plan following treatment, CoC issued a mandate that cancer programs provide SCPs for all curative cancer patients by 2019 to maintain accreditation.

The new requirement may necessitate changes for the majority of radiation oncology programs, according to data from a March 2014 survey of ASTRO members. The survey found that only 40 percent and 19 percent of respondents used SCPs for curative and palliative patients, respectively. Primary barriers to implementation included cost and the lack of a standardized, comprehensive SCP framework suited to patients who received RT. Nearly 80 percent of the RT providers that reported using SCPs relied on a framework developed internally within their practice, indicating that different patients may receive different types of information depending on where they receive treatment.

“This two-page template facilitates consistency in SCPs across the discipline and also reduces the time and effort required by providers to complete each individual plan,” said Ronald Chen, an associate professor in radiation oncology at the University of North Carolina at Chapel Hill and lead author on the manuscript that includes the template.

“The field of radiation oncology has a long tradition of creating treatment summaries for each patient, even before the Institute of Medicine recommended survivorship care plans in 2006. This radiation-oncology specific template will serve a dual purpose as both a traditional radiation oncology treatment summary and a plan for survivorship care that meets CoC requirements – thus reducing the burden on radiation oncologists from having to create two documents for each patient.”

Chen was the chair of ASTRO’s Clinical, Translational and Basic Science Advisory Committee, the group that examined current adoption levels of SCPs and developed the template to standardize them in the future.

YOU MAY BE INTERESTED IN

Shearwood McClelland III’s grandfather was a ditchdigger who dreamed that his six Black daughters would become doctors. McClelland’s mother did not disappoint—she became the first Black woman board-certified in maternal fetal medicine in the history of the United States.  Now, McClelland is the chief medical officer of Cancer Health Equity at the University of Oklahoma...

As oncology enters a new era of precision medicine, the Food and Drug Administration’s evolving biomarker strategy aims to ensure that life-saving therapies are tailored to individual patient needs, fostering safer and more effective treatments.  Historically, therapies were approved with broad indications based on overall efficacy, even when outcomes for biomarker-positive and -negative patients were...

In the evolving landscape of pediatric oncology, survivorship research has become an essential component of our mission to improve long-term patient outcomes. At City of Hope, we are focused on not only curing childhood cancers but also ensuring that survivors live the healthiest lives possible. A significant part of my research has been dedicated to mitigating the long-term toxicities of cancer therapy—particularly cardiovascular complications that can arise decades after treatment.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login